# Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue Sarcoma

> **NCT03056599** · PHASE1 · COMPLETED · sponsor: **Presage Biosciences** · enrollment: 23 (actual)

## Conditions studied

- Soft Tissue Sarcoma Adult

## Interventions

- **DRUG:** Multiple drug microinjection
- **DEVICE:** CIVO device

## Key facts

- **NCT ID:** NCT03056599
- **Lead sponsor:** Presage Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-15
- **Primary completion:** 2021-07-22
- **Final completion:** 2021-09-22
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2021-09-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03056599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03056599, "Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue Sarcoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03056599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*